Hormonal contraceptives are among the most effective and widely requested methods of family planning offered at primary health care (PHC) clinics across Nigeria. These methods use synthetic versions of natural female hormones—estrogen and progestin, or progestin alone—to regulate fertility and prevent unwanted pregnancies. Midwives serving in primary care settings are often the first point of contact for women seeking reliable birth control. Providing these services requires a solid understanding of both the physiological basis of these methods and the practical realities of community-based healthcare delivery. When clients have access to safe, confidential, and culturally sensitive hormonal contraception, maternal mortality rates drop and families are better empowered to plan their futures.
Understanding how hormonal methods work helps midwives explain their use clearly to clients who may hold misconceptions. The three primary ways these hormones prevent conception include:
Hormonal contraceptives are broadly categorized into combined methods containing both estrogen and progestin, and progestin-only methods. Choosing the right option depends on the client's medical history, age, reproductive goals, and personal preferences regarding daily routines versus long-acting devices. Midwives must maintain a diverse stock of these commodities at the PHC level to ensure true method choice for every client.
Combined hormonal contraceptives (CHCs) deliver steady doses of estrogen and progestin to block ovulation and stabilize the uterine lining.
Despite their high efficacy, CHCs carry a small risk of thromboembolism due to the estrogen component, requiring careful screening for blood clotting risk factors, severe headaches, and high blood pressure.
Progestin-only methods (POMs) are excellent alternatives for clients who cannot use estrogen, such as breastfeeding mothers or women with cardiovascular risk factors.
A common side effect of all progestin-only methods is a change in menstrual bleeding patterns, often resulting in amenorrhea or irregular spotting.
Midwives must use the World Health Organization Medical Eligibility Criteria for Contraceptive Use (WHO MEC) to evaluate whether a client can safely use a specific hormonal method. The categories range from Category 1, where there is no restriction for use, to Category 4, where the method presents an unacceptable health risk. Essential screening steps include taking a targeted medical history, measuring blood pressure, and assessing pregnancy status. Midwives should avoid unnecessary physical examinations, such as routine pelvic exams or cervical cancer screening, before initiating most hormonal contraceptives.
Many clients discontinue hormonal contraception prematurely due to harmless side effects or community myths. Midwives must proactively counsel clients about expected changes in bleeding patterns, mild headaches, or breast tenderness before initiation. Many women worry that injectable contraceptives cause permanent infertility, which is scientifically false; fertility usually returns after a delay once the drug clears the system. Empathy, active listening, and clear explanations build the trust needed to keep women using their chosen methods successfully.
Effective counseling goes beyond simply handing out commodities; it involves helping the client select a method that fits her lifestyle and giving her the tools to manage minor problems. Using the REDI or GATHER counseling framework ensures that clients feel heard and supported throughout their reproductive lives. Midwives should encourage clients to return to the clinic if they experience troublesome side effects rather than stopping use in secret. Supportive follow-up significantly improves continuation rates and overall client satisfaction.